Pharmacokinetics of Butyrate Tablet BKR-017

Who May Qualify: - Men and women, ages 18-70 inclusive - Subjects currently on statin treatments. Who Should NOT Join This Trial: - Presence of cirrhosis, or other causes of liver disease - Substantial alcohol consumption (\>20 g/day for women or \>30 g/day for men) - History of bariatric or intestinal surgery - Active gastrointestinal disease including but not limited to irritable bowel syndrome, inflammatory bowel disease (e.g., Crohn's disease and ulcerative colitis), diverticulitis, gastroparesis. - Active and clinically significant pancreatic disease, or renal disease as determined by the investigator. - History of heart disease that in the opinion of the investigator should exclude the subject from the study. - Untreated or uncontrolled hyperthyroidism or hypothyroidism, or other significant thyroid disease - Active significant infection as determined by the investigator. - Known allergy to butyrate or any of the components of the tablets. - Participation in a clinical trial and/or Dosing with an investigational drug during the 30 days before screening, or within 5 half-lives of receipt of an investigational drug or twice the duration of the biological effect of any investigational drug (whichever is longer) - Pregnant, nursing, or trying to become pregnant. - In the investigator's judgment, the subject is not suitable for the study for any other reason or cannot commit to the requirements of the study. - Taking part in another clinical trial or being in the exclusion period of a previous clinical trial. Always talk to your doctor about whether this trial is right for you.